B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

AMY1C

MOLECULAR TARGET

amylase alpha 1C

UniProt: P0DUB6NCBI Gene: 2781 compounds

AMY1C (amylase alpha 1C) is targeted by 1 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting AMY1C

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1scutellarein1.102

About AMY1C as a Drug Target

AMY1C (amylase alpha 1C) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 1 compounds with documented AMY1C interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

AMY1C inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.